|
1
|
Penn I: Cancers complicating organ
transplantation. N Engl J Med. 323:1767–1769. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Andrés A: Cancer incidence after
immunosuppressive treatment following kidney transplantation. Crit
Rev Oncol Hematol. 56:71–85. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caillard S, Dharnidharka V, Agodoa L,
Bohen E and Abbott K: Posttransplant lymphoproliferative disorders
after renal transplantation in the United States in era of modern
immunosuppression. Transplantation. 80:1233–1243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Engels EA, Clarke CA, Pfeiffer RM, Lynch
CF, Weisenburger DD, Gibson TM, Landgren O and Morton LM: Plasma
cell neoplasms in US solid organ transplant recipients. Am J
Transplant. 13:1523–1532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karuturi M, Shah N, Frank D, Fasan O,
Reshef R, Ahya VN, Bromberg M, Faust T, Goral S, Schuster SJ, et
al: Plasmacytic post-transplant lymphoproliferative disorder: A
case series of nine patients. Transpl Int. 26:616–622. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ueda K, Matsui H, Watanabe T, Seki J,
Ichinohe T, Tsuji Y, Matsumura K, Sawai Y, Ida H, Ueda Y and Chiba
T: Spontaneous rupture of liver plasmacytoma mimicking
hepatocellular carcinoma. Intern Med. 49:653–657. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
El Maaroufi H, Doghmi K, Rharrassi I and
Mikdame M: Extramedullary plasmacytoma of the liver. Hematol Oncol
Stem Cell Ther. 5:172–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greipp PR, San Miguel J, Durie BG, Crowley
JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H,
Kyle RA, et al: International staging system for multiple myeloma.
J Clin Oncol. 23:3412–3420. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mahony JF, Caterson RJ, Coulshed S,
Stewart JH and Sheil AG: Twenty and 25 years survival after
cadaveric renal transplantation. Transplant Proc. 27:2154–2155.
1995.PubMed/NCBI
|
|
10
|
Harris NL, Swerdlow SH, Frizzera G, et al:
Post-transplant lymphoproliferative disorders. Pathology and
Genetics: Tumours of Haematopoietic and Lymphoid Tissues: World
Health Organization Classification of Tumours. Jaffe ES, Harris NL
and Stein H: (Lyon, France). IARC Press. 264–269. 2001.
|
|
11
|
Davis NF, McLoughlin LC, Dowling C, Power
R, Mohan P, Hickey D, Smyth G, Eng M and Little DM: Incidence and
long-term outcomes of squamous cell bladder cancer after deceased
donor renal transplantation. Clin Transplant. 27:E665–E668. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Branco F, Cavadas V, Osório L, Carvalho F,
Martins L, Dias L, Castro-Henriques A and Lima E: The incidence of
cancer and potential role of sirolimus immunosuppression conversion
on mortality among a single-center renal transplantation cohort of
1,816 patients. Transplant Proc 2011. 43:137–141. 2011.
|
|
13
|
Knight JS, Tsodikov A, Cibrik DM, Ross CW,
Kaminski MS and Blayney DW: Lymphoma after solid organ
transplantation: Risk, response to therapy, and survival at a
transplantation center. J Clin Oncol. 27:3354–3362. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McKenna RW, Kyle RA, Kuehl RA, Grogan TM,
Harris NL and Coupland RW: Plasma cell neoplasms. WHO
classification of tumours of haematopoietic and lymphoid tissues
(Lyon, France). IARC Press. 200–213. 2008.
|
|
15
|
Caillard S, Agodoa LY, Bohen EM and Abbott
KC: Myeloma, Hodgkin disease, and lymphoid leukemia after renal
transplantation: Characteristics, risk factors and prognosis.
Transplantation. 81:888–895. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tcheng WY, Said J, Hall T, Al-Akash S,
Malogolowkin M and Feig SA: Post-transplant multiple myeloma in a
pediatric renal transplant patient. Pediatr Blood Cancer.
47:218–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Perry AM, Aoun P, Coulter DW, Sanger WG,
Grant WJ and Coccia PF: Early onset, EBV− PTLD in
pediatric liver-small bowel transplantation recipients: A spectrum
of plasma cell neoplasms with favorable prognosis. Blood.
121:1377–1383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Plant AS, Venick RS, Farmer DG, Upadhyay
S, Said J and Kempert P: Plasmacytoma-like post-transplant
lymphoproliferative disorder seen in pediatric combined liver and
intestinal transplant recipients. Pediatr Blood Cancer.
60:E137–E139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Renoult E, Bertrand F and Kessler M:
Monoclonal gammopathies in HBsAg-positive patients with renal
transplants. N Engl J Med. 318:12051988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Radl J, Valentijn RM, Haaijman JJ and Paul
LC: Monoclonal gammapathies in patients undergoing
immunosuppressive treatment after renal transplantation. Clin
Immunol Immunopathol. 37:98–102. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun X, Peterson LC, Gong Y, Traynor AE and
Nelson BP: Post-transplant plasma cell myeloma and polymorphic
lymphoproliferative disorder with monoclonal serum protein
occurring in solid organ transplant recipients. Mod Pathol.
17:389–394. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Richendollar BG, Hsi ED and Cook JR:
Extramedullary plasmacytoma-like post-transplantation
lymphoproliferative disorders: Clinical and pathologic features. Am
J Clin Pathol. 132:581–588. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Trappe R, Zimmermann H, Fink S, Reinke P,
Dreyling M, Pascher A, Lehmkuhl H, Gärtner B, Anagnostopoulos I and
Riess H: Plasmacytoma-like post-transplant lympho-proliferative
disorder, a rare subtype of monomorphic B-cell post-transplant,
lympho-proliferation is associated with a favorable outcome in
localized as well as in advanced disease: A prospective analysis of
8 cases. Haematologica. 96:1067–1071. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Petrucci MT, Tirindelli MC, De Muro M,
Martini V, Levi A and Mandelli F: Extramedullary liver plasmacytoma
a rare presentation. Leuk Lymphoma. 44:1075–1076. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gertz MA and Dingli D: How we manage
autologous stem cell transplantation for patients with multiple
myeloma. Blood. 124:882–890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mikhael JR, Schuster SR, Jimenez-Zepeda
VH, Bello N, Spong J, Reeder CB, Stewart AK, Bergsagel PL and
Fonseca R: Cyclophosphamide-bortezomib-dexamethasone (CyBorD)
produces rapid and complete hematologic response in patients with
AL amyloidosis. Blood. 119:4391–4394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakazato T, Mihara A, Ito C, Sanada Y and
Aisa Y: Lenalidomide is active for extramedullary disease in
refractory multiple myeloma. Ann Hematol. 91:473–474. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ito C, Aisa Y, Mihara A and Nakazato T:
Lenalidomide is effective for the treatment of bortezomib-resistant
extramedullary disease in patients with multiple myeloma: Report of
2 cases. Clin Lymphoma Myeloma Leuk. 13:83–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saboo SS, Fennessy F, Benajiba L, Laubach
J, Anderson KC and Richardson PG: Imaging features of
extramedullary, relapsed, and refractory multiple myeloma involving
the liver across treatment with cyclophosphamide, lenalidomide,
bortezomib, and dexamethasone. J Clin Oncol. 30:e175–e179. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Calvo-Villas JM, Alegre A, Calle C,
Hernández MT, García-Sánchez R and Ramirez G: GEM-PETHEMA/Spanish
Myeloma Group, Spain: Lenalidomide is effective for extramedullary
disease in relapsed or refractory multiple myeloma. Eur J Haematol.
87:281–284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sumrall B, Diethelm L and Brown A Jr:
Multiple myeloma relapse following autologous stem cell transplant
presenting with diffuse pulmonary nodules. Ochsner J. 13:553–557.
2013.PubMed/NCBI
|
|
32
|
Au WY, Lie AK, Chan EC, Pang A, Ma SK,
Choy C and Kwong YL: Treatment of postrenal transplantation
lymphoproliferative disease manifesting as plasmacytoma with
nonmyeloablative hematopoietic stem cell transplantation from the
same kidney donor. Am J Hematol. 74:283–286. 2003. View Article : Google Scholar : PubMed/NCBI
|
